Drug or technology

RNA Research and Splicing

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

Nucleoporins in Cancer: Functional Roles and Therapeutic Opportunities

Cancer Discovery

A narrative review synthesizing mechanistic evidence and therapeutic concepts without reporting new experimental data, clinical trials, or original empirical results.

Hypothesis-GeneratingVerónica Rodríguez-Bravo Marc Carceles‐Cordon Josep Domingo‐Domenech

AUG 12, 2026 · JOURNAL ARTICLE

RNA-Binding Motif Protein 3 as a Therapeutic and Prognostic Target for Drug Discovery

Current Issues in Molecular Biology

A literature review synthesizing mechanistic and exploratory evidence on RBM3 function across diseases, raising questions about therapeutic potential rather than answering them with clinical trial data.

Hypothesis-GeneratingMarvin A. Larbi Dmitriy Minond RNA Research and Splicing

Study details

DesignNarrative literature review

JUL 28, 2026 · JOURNAL ARTICLE

Flow Cytometric Evaluation of SYTO 9 Green Staining in Empty and Loaded Lipid Nanoparticles Using the CytoFLEX nano Flow Cytometer 2302379

The Journal of Immunology

A methodological study optimizing a flow cytometric protocol for LNP characterization with no clinical or in vivo validation; demonstrates technical feasibility but lacks independent replication or validation against established standards.

PreliminaryAnisha Jose RNA Research and Splicing Evgenia Kim

Reported

Empty LNP background staining≤1% positive events

SYTO 9 Green dye concentration ra…25 µM to 3.125 µM